Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT03755700

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03755700
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03755700. Randomized; double masking; primary purpose prevention. Start 2018-11-01 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
Condition
Coronary Artery Angiography
Condition
Coronary Catheterization
Condition
Contrast-induced Nephropathy
Condition
Stable Angina
Condition
Acute Coronary Syndrome
Intervention (Drug)
Vitamin E
Intervention (Drug)
N-acetyl cysteine
Intervention (Drug)
Placebo oral capsule
Intervention (Drug)
Placebos
Intervention (Drug)
Normal Saline Flush, 0.9% Injectable Solution
Lead sponsor
Rajaie Cardiovascular Medical and Research Center (class: other)

Record details

Record id
cardio:ct-nct03755700
Content hash
f4684e3afcc5abbd4ef6885e88c574994d66d8b285b75f60da39c90e7a50ed02